Matthew S. Holt - Mar 29, 2023 Form 4 Insider Report for Signify Health, Inc. (SGFY)

Role
Director
Signature
/s/ Adam McAnaney, as attorney-in-fact for Matthew S. Holt
Stock symbol
SGFY
Transactions as of
Mar 29, 2023
Transactions value $
$0
Form type
4
Date filed
3/29/2023, 08:47 AM
Previous filing
Jun 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGFY Class A Common Stock Disposed to Issuer -14.7K -100% 0 Mar 29, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Matthew S. Holt is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU.